title: High rate of febrile neutropenia in patients with operable breast cancer receiving docetaxel and cyclophosphamide.
authors: Derrick
authors: D
authors: Soong
authors: Reem
authors: R
authors: Haj
authors: Mova G
authors: MG
authors: Leung
authors: Robert
authors: R
authors: Myers
authors: Brian
authors: B
authors: Higgins
authors: Jeff
authors: J
authors: Myers
authors: Sudha
authors: S
authors: Rajagopal
mesh_terms: D019072:Antibiotic Prophylaxis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D000077143:Docetaxel; D005334:Fever / Q000139:chemically induced* / Q000517:prevention & control; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced* / Q000517:prevention & control; D043823:Taxoids / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D043823:Taxoids; D016179:Granulocyte Colony-Stimulating Factor; D000077143:Docetaxel; D003520:Cyclophosphamide